Start-Up Spotlight: NovaSignal Aims To Commercialize Transcranial Ultrasound
With a mostly forgotten imaging modality, NovaSignal is trying to create the “fifth vital sign.” Medtech Insight spoke to chairman and chief executive officer, Diane Bryant, to learn more about the company's transcranial ultrasound technology.
You may also be interested in...
A CDC study found that fewer than half of children with sickle cell disease were getting screened for strokes, and fewer than 40% of children were taking recommended medications.
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.